Schedule 13G ownership disclosure
Immunic Inc
Common Stock · CUSIP: 4525EP101
Event date: 2024-12-31
- Filing-level shares
- 3,923,763
- Percent of class
- 4.35%
- The Vanguard Group
Shares: 3,923,763 · Class: 4.35%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000155
- Form type
- SCHEDULE 13G/A
- Filer
- IMMUNIC, INC.
- CIK
- CIK 1280776
- Filed
- Jan 30, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership